Fiorinal W/codeine No 3

   
Google
 
Web NewDrugInformation.com

Fiorinal W/codeine No 3


Drug - Fiorinal W/codeine No 3
The trade name of the product as shown on the labeling.

Dosage - CAPSULE; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Aspirin; Butalbital; Caffeine; Codeine Phosphate
Multiple ingredients are in alphabetical order.

Strength - 325MG;50MG;40MG;30MG
The potency of the active ingredient(s), Aspirin; Butalbital; Caffeine; Codeine Phosphate. May repeat for multiple part products.

Applicant - WATSON PHARMS
The firm name holding legal responsibility for Fiorinal W/codeine No 3. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 019429
The FDA assigned number to Fiorinal W/codeine No 3. Format is nnnnnn.

Product Number - 003
The FDA assigned number to identify Fiorinal W/codeine No 3. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AB
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Oct 26, 1990
The date Fiorinal W/codeine No 3 was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Fiorinal W/codeine No 3. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Fiorinal W/codeine No 3 is in. Format is RX, OTC, DISCN.

Applicant Full Name - Watson Pharmaceuticals Inc
The full name of the firm holding legal responsibility for the new application of Fiorinal W/codeine No 3.

Fiorinal W/codeine No 3